Study Finds That Anticholingeric Medications Increase Risk of Pneumonia
Psychiatric News Alert|
A study of 3,000 seniors has shown that medications with anticholinergic effects (those that block the neurotransmitter acetycholine) are associated with a higher risk of developing pneumonia.
Drugs that have anticholinergic properties treat a wide swath of conditions, many of which are common in older adults; these include asthma, COPD, gastrointestinal disorders, and bladder problems. Anticholinergic drugs are also important therapies for mental disorders; benzodiazepines and tricyclic antidepressants fall into this category.
A team from the Group Health Research Institute in Seattle examined health and pharmacy data from 1,039 cases of pneumonia that occurred among their older, immune, competent patients (65-94) as well as 2,000 healthy controls of the same age and gender composition.
They found that 59% of the pneumonia cases had one or more prescription fills of an anticholinergic 90 days or less before the diagnosis, compared with 35% of the healthy group. The pneumonia group also showed higher chronic anticholinergic use, with 53% of the patients having filled three or more prescriptions over the past year, compared with 36% of the controls.